Chesley Taft & Associates’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-7,500	Closed	-$1.03M	–	315
2024 Q1	$1.03M	Buy	+7,500	New	+$1.03M	0.05%	183